论文部分内容阅读
乙胺碘呋酮治疗小儿快速型心律失常30例。年龄最小1(7/30)月,最大13岁。疗效显著,特别是近期有效率93.3%,其中3例静脉用药治疗阵发性室上性心动过速2例显效迅速。经随访部分早搏病例有复发,但再用或加至原剂量仍有效,维持用药最长16月。口服副作用小,有心动过缓,心电图P-R或Q-T间期延长、皮疹、恶心、眼角膜微粒沉着及光晕感,未发现甲状腺功能明显变化。1例静脉注射发生完全性房室传导阻滞、血压下降等严重反应,故强调静脉用药应严格控制剂量及速度、心肌病、心脏肥大者相对禁用。
Ethniodoxurone in treating 30 children with tachyarrhythmia. The youngest 1 (7/30) months, maximum 13 years old. Significant effect, especially the recent 93.3% efficiency, of which 3 cases of intravenous treatment of paroxysmal supraventricular tachycardia in 2 cases markedly effective. Some cases of early follow-up of cases of recurrent relapse, but re-use or added to the original dose is still valid to maintain the longest medication in 16 months. Small oral side effects, bradycardia, electrocardiogram P-R or Q-T interval prolongation, rash, nausea, corneal corneal deposition and aura, did not find significant changes in thyroid function. One case of intravenous injection of complete atrioventricular block, blood pressure and other serious reactions, it is stressed intravenous medication should be strictly controlled dose and speed, cardiomyopathy, cardiac hypertrophy were relatively disabled.